Bhumirajanagarindra Kidney Institute
Bangkok, 10400, Thailand
NCT Number: NCT02194790
Chronic kidney disease (CKD) is a major health problem in Thailand. Previous studies have demonstrated that integrated pre-dialysis care may slow the decline in renal function (Nephrol Dial Transplant.2009 Nov;24(11):3426-33). It is interesting to know whether early intervention especially in high risk groups like Diabetic may also improve outcome of these patients in primary health care setting resulting in delay of CKD progression.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Bangkok, 10400, Thailand
We conducted a 12-month longitudinal study at district A (control) and B (intervention) at Kamphaeng Phet Province, Thailand. Diabetic patients with eGFR ≥ 60 ml/min/1.73m2 were recruited from both districts. Patients in district A (control group) received standard CKD care according to NKF-K/DOQI guidelines1 whereas those in district B (intervention) received, in addition to the standard care, educational activities provided by nutritionist, pharmacist and physiotherapist, and quarterly home visits. Our home visits team consisted of nurse, health care officers and village health volunteers. During each hospital visit of both groups clinical data were assessed. All laboratory parameters were collected every 3 months, and LDL and HbA1C every 6 months. The primary end point was rate of eGFR decline. Secondary outcomes were random urine albumin to creatinine ratio (ACR), blood pressure, waist circumference, HbA1C and LDL .
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients received, in addition to the standard care, educational activities provided by nutritionist, pharmacist and physiotherapist, and quarterly home visits. Our home visits team consisted of nurse, health care officers and village health volunteers
Other names: Multidisciplnary clinic + home visit team
Time frame: 12 months
We compare the difference of rate of eGFR decline from baseline end of the study between the intervention group and control group.
Time frame: 12 months
Time frame: 12 months
Time frame: 12 months
Time frame: 12 months
Time frame: 12 months
Bhumirajanagarindra Kidney Institute, Thailand
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00811889
Chronic Disease, Chronic Kidney Disease
Birmingham, Alabama, United States
View Trial DetailsNCT00920764
Chronic Disease, Chronic Kidney Disease
Tempe, Arizona, United States
View Trial DetailsNCT01424319
Chronic Disease, Chronic Kidney Disease
Azumino, Japan
View Trial DetailsNCT01399580
Chronic Disease, Chronic Kidney Disease
Phoenix, Arizona, United States
View Trial Details